Osteopore Statistics

Total Valuation

Osteopore has a market cap or net worth of AUD 2.39 million. The enterprise value is 3.04 million.

Market Cap	2.39M
Enterprise Value	3.04M

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Osteopore has 170.90 million shares outstanding. The number of shares has increased by 719.13% in one year.

Current Share Class	n/a
Shares Outstanding	170.90M
Shares Change (YoY)	+719.13%
Shares Change (QoQ)	-63.36%
Owned by Insiders (%)	10.40%
Owned by Institutions (%)	17.51%
Float	119.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.87
PB Ratio	7.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.91
EV / Sales	1.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.98

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 4.35.

Current Ratio	0.86
Quick Ratio	0.64
Debt / Equity	4.35
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-6.91

Financial Efficiency

Return on equity (ROE) is -907.51% and return on invested capital (ROIC) is -116.36%.

Return on Equity (ROE)	-907.51%
Return on Assets (ROA)	-56.81%
Return on Invested Capital (ROIC)	-116.36%
Return on Capital Employed (ROCE)	-707.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.85
Inventory Turnover	1.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.80% in the last 52 weeks. The beta is -0.28, so Osteopore's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-88.80%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	37.26
Average Volume (20 Days)	3,536,865

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Osteopore had revenue of AUD 2.76 million and -3.35 million in losses. Loss per share was -0.04.

Revenue	2.76M
Gross Profit	2.30M
Operating Income	-2.94M
Pretax Income	-3.33M
Net Income	-3.35M
EBITDA	-2.47M
EBIT	-2.94M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 682,264 in cash and 1.33 million in debt, giving a net cash position of -648,478 or -0.00 per share.

Cash & Cash Equivalents	682,264
Total Debt	1.33M
Net Cash	-648,478
Net Cash Per Share	-0.00
Equity (Book Value)	306,220
Book Value Per Share	0.00
Working Capital	-368,360

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.09 million and capital expenditures -14,590, giving a free cash flow of -3.10 million.

Operating Cash Flow	-3.09M
Capital Expenditures	-14,590
Free Cash Flow	-3.10M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 83.08%, with operating and profit margins of -106.57% and -121.34%.

Gross Margin	83.08%
Operating Margin	-106.57%
Pretax Margin	-120.65%
Profit Margin	-121.34%
EBITDA Margin	-89.23%
EBIT Margin	-106.57%
FCF Margin	n/a

Dividends & Yields

Osteopore does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-719.13%
Shareholder Yield	-719.13%
Earnings Yield	-140.12%
FCF Yield	-129.67%

Stock Splits

The last stock split was on February 23, 2024. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Feb 23, 2024
Split Type	Reverse
Split Ratio	0.0666666667

Scores

Osteopore has an Altman Z-Score of -9.31. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.31
Piotroski F-Score	n/a